logo
Medscape InDiscussion: Type 2 Diabetes

Medscape InDiscussion: Type 2 Diabetes

Network: Medscape

Overview

Medscape InDiscussion: Type 2 Diabetes is an essential resource for US healthcare professionals seeking to deepen their expertise in managing type 2 diabetes. Each episode features leading clinical experts who provide evidence-based insights and practical strategies for optimizing patient care, covering advanced topics such as continuous glucose monitoring, navigating patient resistance, and pharmacological interventions for co-morbidities like chronic kidney disease. The podcast offers a professional, in-depth exploration of current guidelines, emerging technologies, and complex clinical scenarios, making it invaluable for practitioners aiming to stay abreast of the latest advancements and enhance their clinical decision-making in diabetes management.

Show Impressions

Estimates only, not verified by show

Est. Podcast Downloads

80



Recent Campaigns


Demographics

Location

Fans by country:

United States 88%
Canada 4%
United Kingdom 3%
Germany 3%
Australia 2%

Age Distribution

18-24
12.0%
25-34
28.0%
35-44
26.0%
45-54
18.0%
55-64
11.0%
65-99
5.0%

Income Brackets

$50k-60k
13.0%
$60k-70k
12.0%
$40k-50k
11.0%
$70k-80k
11.0%
$80k-90k
10.0%
$30k-40k
9.0%
$90k-100k
9.0%
$100k-150k
8.0%
$20k-30k
7.0%
$10k-20k
4.0%
$150k-200k
4.0%
$200k-1000k
2.0%

Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Top Advertisers

Top Spenders
Est. Spent
Change
Host Read %
DR %
# of ads
Frequency
Top Shows
Medscape

Medscape

$10.0%100.0%100.0%
2.0ad units
Test run
This Week in CardiologyMedscape InDiscussion: Type 2 Diabetes
+1

Ads and Episodes

S3 Episode 5: Choosing Which Agents to Use in the Management of CKD in Type 2 Diabetes Patients: SGLT2 Inhibitors vs GLP-1s

S3 Episode 5: Choosing Which Agents to Use in the Management of CKD in Type 2 Diabetes Patients: SGLT2 Inhibitors vs GLP-1s

0:00 / 0:31
Direct Response
S
#1
Run on 1x episode




Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Recent Episodes